Redesign Science
PrivateLast Round
Seed
Dec 8, 2021
Total Funding Raised
$17M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Redesign Science operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in December 2021.
Redesign Science is a biotechnology company that utilizes advanced biomolecular simulations and generative AI to discover small molecule therapeutics for challenging drug targets.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Redesign Science Comparables
Compare Redesign Science with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qubit Pharmaceuticals | 87% | |
| PsiThera | 86% | |
| Fathom Therapeutics | 83% |
For institutional investors. Book with your work email.
Redesign Science Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 8, 2021 | ||||
| Seed | Dec 8, 2021 | ||||
| Seed | Oct 7, 2019 |
For institutional investors. Book with your work email.
Redesign Science Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Refactor Capital | Seed |
| Kaitai Capital | Seed |
| ZhenFund | Seed |
| Acequia Capital | Seed |
| Notation Capital | Seed |
| Hawktail Management | Seed |
| Collaborative Fund | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 62% to 2,000.
- Apr 9, 2026
Monthly visitors increased 31% MoM.
For institutional investors. Book with your work email.
Redesign Science Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Redesign Science's valuation, stock price, and market status.
Is Redesign Science a public or private company?
Redesign Science is a private company.
What is the current stock price of Redesign Science?
Redesign Science is a private company, so its shares have no public market price. Caplight tracks Redesign Science's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Redesign Science worth (valuation)?
Valuation information for Redesign Science is not publicly available.
Can I buy Redesign Science stock?
Redesign Science shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Redesign Science's last funding round?
Redesign Science's most recent funding round was Seed on December 8, 2021.
Who are the main investors in Redesign Science?
Key investors in Redesign Science include Kaitai Capital, Notation Capital, Collaborative Fund.
Will Redesign Science IPO soon?
No public IPO plans have been announced for Redesign Science.
How can I track Redesign Science secondary market activity?
Caplight tracks bids, offers, and trades in Redesign Science's shares on secondary markets.